Post by Miltenyi Biotec

Innovation in cell therapy takes time. We’re proud to see this recognized: Dr. Mario Assenmacher, Miltenyi Biotec, has received the 2026 ESACT - European Society for the Advancement of Cell Technology Innovation Award for his contributions to immune cell technologies advancing cell and gene therapies. The award honors outstanding innovation in animal cell culture technology, a foundation of modern biopharma. From early concepts to scalable solutions, this work helps bring therapies closer to patients – and reflects the kind of science we strive to enable at Miltenyi Biotec. Congratulations, Mario, on this well-deserved recognition. #innovation #celltherapy #miltenybiotec